We recruit verified physicians, specialists, and patient populations across condition areas — including hard-to-reach segments in both public and private hospital settings.

Thailand is Southeast Asia’s most developed medical market and a growing hub for pharmaceutical, medical device, and digital health companies expanding across the region. Research in this sector demands more than standard methodology — it requires access to respondents who are genuinely difficult to reach, sensitivity to disclosure norms around diagnosis and treatment, and fieldwork expertise that can navigate Thailand’s hospital and clinic environment.
At Iconic Research, we support healthcare and life sciences clients with patient and physician recruitment, qualitative and quantitative fieldwork, and consumer research across Thailand’s public and private health sectors. For multi-country projects, we coordinate research across ASEAN through partners in Singapore, Malaysia, Indonesia, Vietnam, and the Philippines.
Healthcare research in Thailand draws a specific client profile. Our work spans:
Pharmaceutical companies validating brand perception, treatment awareness, and prescribing behavior across therapeutic areas — from primary care to specialist segments.
Medical device and MedTech companies entering the Thai market who need to understand purchasing decision-makers, procurement pathways, and clinical adoption barriers before they brief their regional team.
Digital health and health-tech companies testing product concepts, measuring user experience, and understanding how Thai patients and providers interact with health technology in practice.
Hospitals and health systems commissioning patient experience research, service quality studies, and community health needs assessments.
Government agencies and health NGOs requiring population health surveys, policy feedback studies, and public health communication testing.
Recruiting verified patients in Thailand requires navigating hospital gatekeeping, patient privacy norms, and the sensitivity of health disclosure in Thai culture. We maintain established networks across Bangkok’s private hospitals and public health facilities, with fieldwork teams experienced in patient-facing research.
We recruit across condition areas including oncology, cardiovascular, diabetes, respiratory, and rare disease — as well as caregivers and family decision-makers whose role in Thai healthcare decisions is frequently underestimated.
Gaining honest, unguarded responses from Thai doctors requires more than a screener and an honorarium. Physicians in Thailand range from private clinic owners to hospital-based specialists operating within strict institutional hierarchies — and research design needs to reflect that.
We conduct in-depth interviews, focus groups, and structured surveys with GPs, specialists, pharmacists, and nurses. Our HCP recruitment is verified against medical licensing where required, and our moderators and interviewers have experience navigating the professional sensitivities that shape how medical professionals respond in research settings.
Focus groups and in-depth interviews in healthcare require particular care around topic sensitivity, respondent comfort, and disclosure boundaries. Patients discussing diagnosis, treatment adherence, or side effects need environments where they feel safe to speak honestly — not standard focus group facilities with one-way mirrors and clipboards.
We design healthcare qualitative research to match the sensitivity of the subject matter: venue selection, moderator briefing, consent protocols, and analysis that reads between the lines of what participants say and what they mean.
For large-scale patient surveys, treatment tracking studies, or HCP quantitative work, we combine online and offline methodologies depending on the segment. Patient populations in Thailand’s public health system are frequently offline-first — our CAPI fieldwork teams reach respondents that online panels cannot.
We recruit verified physicians, specialists, and patient populations across condition areas — including hard-to-reach segments in both public and private hospital settings.
Yes. We have fieldwork teams across Thailand's regions and conduct research in provincial hospitals and community health settings, not just urban private clinics.
All fieldwork is conducted in Thai. Recruitment, moderation, and research instruments are built in Thai first. Analysis and reporting are delivered in English for international clients.
Pharma, medical devices, MedTech, digital health, hospital services, and public health. We work with multinational companies, regional health agencies, and NGOs.
Timelines vary by scope. Patient recruitment studies typically run 4–8 weeks. Physician IDI projects can move faster depending on specialty and sample size. We provide a project timeline at briefing stage.
Healthcare research in Thailand requires more than methodology — it requires access. To the right doctors, the right patients, the right institutions. Without it, you have a research design and no data worth trusting.
Healthcare research in Thailand fails when it treats respondents like any other sample.
Thai hospitals — particularly public institutions — are not open to unsolicited researcher access. Reaching verified patients with specific conditions, or specialist physicians in particular therapeutic areas, requires established relationships and fieldwork infrastructure that most general research agencies do not have.
Thai patients frequently underreport symptoms, treatment non-compliance, and dissatisfaction with care — not from dishonesty but from cultural norms around not burdening others and deference to medical authority. Research design and moderation need to account for this explicitly.
Thailand's healthcare system operates across a stark divide between well-resourced private hospitals serving urban professionals and international visitors, and the public system serving the majority of the population. Research that only reaches private hospital patients misses most of the market.
Research instruments built in English and translated into Thai routinely produce artefacts — not insights. Medical terminology, condition stigma, and the way Thai patients describe symptoms to doctors versus to researchers are different registers entirely. Our materials are built in Thai first, by researchers who understand the clinical and cultural context simultaneously.